Sino Biopharmaceutical; trustee buys 4.7 million shares at HK$5.8814 under restricted share award scheme

Reuters03-27
<a href="https://laohu8.com/S/SBHMY">Sino Biopharmaceutical</a>; trustee buys 4.7 million shares at HK$5.8814 under restricted share award scheme
  • Sino Biopharmaceutical said the trustee under its restricted share award scheme bought 4,650,000 shares in the market to hold on trust for selected participants.
  • The purchase represented about 0.025% of the company’s shares in issue.
  • The average price was about HKD 5.88 per share, for total consideration of about HKD 27.3 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12072898), on March 27, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment